Back to Journals » ImmunoTargets and Therapy » Volume 15
ImmunoTargets and Therapy
- View all (339)
- Volume 15, 2026 (37)
- Volume 14, 2025 (90)
- Volume 13, 2024 (56)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 15, 2026
- default (37)
- Autoimmune Disease (4)
Role of Cytokines in Bone Diseases and Their Therapeutic Application
Guha A, Wahi P, Lal G
ImmunoTargets and Therapy 2026, 15:604392
Published Date: 7 May 2026
Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumors
Fountzilas E, Kurzrock R, Nishizaki D, Szabo A, Pabla S, DePietro P, Jensen TJ, Kato S, Tsimberidou AM
ImmunoTargets and Therapy 2026, 15:578703
Published Date: 4 May 2026
Tumor-Promoting Crosstalk of MMP11⁺ Fibroblasts and SPP1⁺ Macrophages Drive Poor Prognosis in Breast Cancer: Integrated Multi-Omics Analysis
Huang R, Zhan Z, Huang S, Cao W, Li J, Mao M
ImmunoTargets and Therapy 2026, 15:564498
Published Date: 29 April 2026
RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infection
Guan Z, Ao X, Zhou L, Yu C, Zhang Z, Li D
ImmunoTargets and Therapy 2026, 15:568661
Published Date: 27 April 2026
Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort
Mitura-Lesiuk M, Najda P, Rdzanek O, Bogucka J, Różycka K, Dubaj M, Zawitkowska J
ImmunoTargets and Therapy 2026, 15:603087
Published Date: 23 April 2026
New Insights on IgA Nephropathy from the Perspective of Active Lesions and Systemic Inflammatory Responses
Yang Y, Xu G
ImmunoTargets and Therapy 2026, 15:585437
Published Date: 21 April 2026
Multi-Omics Analysis Reveals m7G Methylation-Related Genes May Be Involved in TGF-β Signaling-Mediated Anti-PD-L1 Response in Bladder Cancer
Liang HQ, Li YJ, Yu JY, Mo QZ, Wei QJ, Liang YQ, Wei FY, Zhang XP, Zhao JW, He YX, Feng XD, Yin BT, Liang XW, Nong RJ, Wang YY, Qin M, Cheng JW
ImmunoTargets and Therapy 2026, 15:583577
Published Date: 14 April 2026
Cryoablation Plus Immune Checkpoint Inhibitors Enhanced Dendritic Cell and T Cell Activation in TNBC Murine Model
Sardela de Miranda F, Babcock RL, Mahecha MF, Gukhool PJ, Boligala GP, Garcia AK, Martinez-Marin D, Oliver AG, Hintelmann T, Furr KL, Bose C, Almodovar S, Singh SP, Pruitt K, Melkus MW, Layeequr Rahman R
ImmunoTargets and Therapy 2026, 15:581990
Published Date: 7 April 2026
Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management
Freiha J, Min YG, Osman C, Rajabally YA
ImmunoTargets and Therapy 2026, 15:390161
Published Date: 2 April 2026
Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphoma
Rohde M, Singh VK, Wolfermann A, Burkhardt B, Blattmann C, Steinbach D, Schneider DT, Ebinger M, Maecker-Kolhoff B, Braun M, Kurch L, Mauz-Körholz C, Körholz D
ImmunoTargets and Therapy 2026, 15:577426
Published Date: 1 April 2026
Comparative Clinical and Electrophysiological Profiles of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes Mellitus: An Observational Study
Al Mamun A, Sumi MSN, Hussain ME, Khan AAM, Rassel MA, Kawnayn G, Yusuf MA, Ranjan R, Moureen A, Adhikary D, Alam MB, Mohammad QD, Karim MN
ImmunoTargets and Therapy 2026, 15:592658
Published Date: 26 March 2026
Progress on Potential Therapeutic Targets for Sepsis-Related Cardiac Dysfunction: From Basic Research to Clinical Translation
Gao Y, Dai R, Kong C, Niu Z, Yuan L, Liu X
ImmunoTargets and Therapy 2026, 15:580700
Published Date: 21 March 2026
Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
Sadanaga T, Jeong HS, Cortez R, Lee JH, Kamle S, Ma B, Shin SJ, Elias JA, Lee CG
ImmunoTargets and Therapy 2026, 15:563951
Published Date: 19 March 2026
The Role of PD-L1 in Lung Cancer: From Biology to Clinical Application
Lamghari H, Karkouri M
ImmunoTargets and Therapy 2026, 15:591588
Published Date: 19 March 2026
NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis
Kong W, Hu Y, Zhang K, Zhu Z, Zou Y, Teng L, Wang X, Zhang J
ImmunoTargets and Therapy 2026, 15:541852
Published Date: 17 March 2026
The Conjugation of Antibodies to Heat Shock Protein 70 Activates Immune Responses Against Tumor Cells
Khosravi M, Rajaei A, Mohammadian B, Seyfi Abad Shapouri M
ImmunoTargets and Therapy 2026, 15:565942
Published Date: 16 March 2026
Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPID
Gualtiero G, Buso H, Coopmans EC, Milito C, Firinu D, Dalm VA, Cinetto F
ImmunoTargets and Therapy 2026, 15:582718
Published Date: 7 March 2026
Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies
Cao Z, Tong S, Wang Z, Ji C, Zhang C, Dai X, Wu B
ImmunoTargets and Therapy 2026, 15:581012
Published Date: 5 March 2026
UVB Upregulates Inflammatory Cytokines in Rosacea Cell Model by Promoting the Expression of TRPVs and TLR2
Xie Y, Hu Y, Huang J, Liu J, Zhang Q
ImmunoTargets and Therapy 2026, 15:571037
Published Date: 4 March 2026
Targeting STING Signalling Polarizes Tumor-Associated Neutrophils to Boost Anticancer and Abscopal Antimetastatic Functions
Drzyzga A, Czapla J, Cichoń T, Matuszczak S, Pilny E, Jarosz-Biej M, Ciepła J, Smolarczyk R
ImmunoTargets and Therapy 2026, 15:576457
Published Date: 19 February 2026
The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons
Gu H, Hu B, Jiang Y
ImmunoTargets and Therapy 2026, 15:572970
Published Date: 19 February 2026
The Dual Mechanism of Action of CO-005 Overcomes CD20 Resistance in Diffuse Large B-Cell Lymphoma
Matar S, Skah S, Moltu LE, Åmellem Ø, Hagland HR, Hestdal K, Pettersen RD, Richartz N
ImmunoTargets and Therapy 2026, 15:572396
Published Date: 19 February 2026
Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
Li B, Jiang S, Yang F, Tang M, Lv H, Li L, Chang J
ImmunoTargets and Therapy 2026, 15:554731
Published Date: 16 February 2026
Recent Advances in Vitiligo Treatment
Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F
ImmunoTargets and Therapy 2026, 15:577653
Published Date: 11 February 2026
Enhancing NK Cell Activity in Colorectal Cancer with an Fc-Optimized Antibody Targeting CD276 (B7-H3)
Stefańczyk SA, Kaiser X, Hagelstein I, Lutz MS, Holzmayer SJ, Zekri L, Märklin M, Jung S
ImmunoTargets and Therapy 2026, 15:533342
Published Date: 10 February 2026
A Novel Prognostic Signature Composed of Autophagy and Liver Metastasis in Colorectal Cancer: Comprehensive Analysis of Bulk and Single-Cell Transcriptomic Data
Bai B, Cui Y, Zhong X, Zhu B, Meng Z, Chen L, Di L, Huang L, Wang J, Jin Z, Lu X, Zhou B
ImmunoTargets and Therapy 2026, 15:563779
Published Date: 6 February 2026
Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders
Blitshteyn S, Doherty TA, Steinman L
ImmunoTargets and Therapy 2026, 15:581262
Published Date: 2 February 2026
Enhancing Anti-CTLA-4 Antibody Delivery to the Brain Using Focused Ultrasound and Microbubbles
Afonso Pereira M, Drevenakova V, Liu QE, Grewal S, Morse SV
ImmunoTargets and Therapy 2026, 15:569804
Published Date: 2 February 2026
Emerging Predictive Biomarkers of Immunotherapy Sensitivity in Patients with Non-Small Cell Lung Cancer
Gariazzo E, Colamartini F, Ubaldi M, Santo V, Brunetti L, Tomarelli C, Ognissanti D, Nassar J, Costabile S, Romano L, De Vita E, Scorpiniti I, Macrì M, Porreca R, Currà MF, Cortellini A, Ricciuti B, Metro G
ImmunoTargets and Therapy 2026, 15:567238
Published Date: 2 February 2026
Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib
Chen J, Situ Y, Cai J, Liao W, Jiang D, Huang C, Zheng J, Peng L, Lin H
ImmunoTargets and Therapy 2026, 15:569823
Published Date: 22 January 2026
A Retrospective Study on the Clinical Characteristics and Management of Immune-Related Adverse Events in Gynecologic Cancer Patients Treated with Immune Checkpoint Inhibitors
Xia Y, Gao S, Wei Q, Gu W, Li X, Qu H
ImmunoTargets and Therapy 2026, 15:566542
Published Date: 21 January 2026
The Value of the Preoperative Hematological Inflammatory Markers for Predicting Lymphovascular Invasion in Gastric Cancer
Li C, Wang Y, Liang S, Shi H, Mao X, Wang X, Mo D
ImmunoTargets and Therapy 2026, 15:564201
Published Date: 9 January 2026
Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study
Zeng H, Wu Y, Zhang Z, Liu J, Sun J, Liu X, Gu Y, Tian M, Chen W, Shen Z, Shen K, Xu C, Wang X, Tang Z, Sun Y
ImmunoTargets and Therapy 2026, 15:564230
Published Date: 9 January 2026
Macrophage-Derived Transcriptional Signatures Predict Prognosis and Drug Sensitivity in Thyroid Cancer: Integrative Analysis and Experimental Validation of SMYD3
Xu S, Zhang X, Sun J, Qin M, Du H, Luo B
ImmunoTargets and Therapy 2026, 15:565624
Published Date: 9 January 2026
Identification of Comprehensive Landscape of Peripheral Immunity and Chemokine-Related Genes in Amyotrophic Lateral Sclerosis
Yang X, Huang S, Wang Y, Yuan J, Yao X
ImmunoTargets and Therapy 2026, 15:566733
Published Date: 9 January 2026
Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG
Ma T, Liu Y, Zhu Y, Gao Y, Wang X, Liang Y, Wang B, Zhu R
ImmunoTargets and Therapy 2026, 15:559497
Published Date: 8 January 2026
Risk and Management of Bowel Obstruction in Colorectal Cancer Patients Undergoing Immunotherapy: A Cross-Sectional Multicenter Study
Hong ZG, Xiao B, Zheng M, Yang W, Zhu L, Liang G, Luo Y, Tang J, Mei W, Yu JH, Hou Z, Wu X, Ding P, Jiang W
ImmunoTargets and Therapy 2026, 15:563431
Published Date: 6 January 2026
